BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  NewLink Genetics’ Indoximod + PROVENGE Results In Statistically Significant Improvement In Radiographic Progression-Free Survival (rPFS) For Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) In Phase II Trial

  June 5, 2017

   · 

  4 min read
• Lone Star Bio

  Caris Life Sciences’ Molecular Intelligence Platform Measures Prevalence Of Oncogenic Homologous Recombination Pathway Mutations Across 53,000 Tumors

  June 5, 2017

   · 

  5 min read
• St. Jude Children’s Research Hospital Release: Chronic Health Conditions Among Long-Term Survivors Of Childhood Cancer Decrease Over Three Decades As Treatments Improve

  June 5, 2017

   · 

  4 min read
• Drug Development

  Puma Biotech Announces Positive PB272 Phase II Data From TBCRC 022 Trial In Patients With HER2-Positive Metastatic Breast Cancer With Brain Metastases At The 2017 ASCO Annual Meeting

  June 5, 2017

   · 

  6 min read
• Pharm Country

  Phosphorus Diagnostics Launches Diagnostic Genetic Tests for Hereditary Cancers

  June 5, 2017

   · 

  3 min read
• Drug Development

  Aileron Therapeutics Release: Anti-Tumor Activity Observed In Phase I Trial Of Novel P53-Targeting Drug ALRN-6924

  June 5, 2017

   · 

  4 min read
• Biotech Beach

  Endologix Presents Positive Two-Year Clinical Data From The Nellix EVAS FORWARD IDE Trial

  June 5, 2017

   · 

  4 min read
• Pharm Country

  Cornerstone Pharmaceuticals, Inc. Announces Corporate Name Change to Rafael Pharmaceuticals

  June 5, 2017

   · 

  2 min read
• Drug Development

  NeuroDerm Presents ND0612H Phase II Trial Results In Late-Breaking Poster Session At The 21st International Congress Of Parkinson’s Disease And Movement Disorders

  June 5, 2017

   · 

  8 min read
• Drug Development

  Nanobiotix : Promising Data From Phase I/II Head And Neck Cancer Trial With NBTXR3 Presented At The ASCO’s Annual Meeting

  June 5, 2017

   · 

  10 min read